GLENMARK PHARMACEUTICALS INC., USA
ent_019e6aa54ce3ab12890b2f22e9ce6daf
Disclosures
2
State AG · 2 jurisdictions
Multi-filing incidents
—
no multi-filing incident in sample
Max affected reported
1
as filed · State AG IN
Leak-site claims
0
none in sample
Identity resolution
- Canonical name
- GLENMARK PHARMACEUTICALS INC., USA
- Normalized
- glenmark pharmaceuticals inc usa— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- 549300P2PTIYYGIM8U12
- SEC EDGAR CIK
- None — not an SEC registrant
- Domain
- None on record
- Corporate parent
- GLENMARK PHARMACEUTICALS LIMITED— per GLEIF relationship records
Disclosure history (2)newest first
- Massachusetts State AGas victim2026-03-27
Glenmark Pharmaceuticals Inc., USA notified individuals of a security incident after receiving an extortion email on February 27, 2026, claiming possession of company records. The investigation identified documents containing government-issued identification numbers. The company engaged external cybersecurity professionals and law enforcement. Two years of identity protection services are being offered. The investigation is ongoing.
- Indiana State AGas victim2026-03-17
Glenmark Pharmaceuticals Inc USA reported a data breach to the Indiana Attorney General. The breach occurred on 2026-02-27 and was reported on 2026-03-17. 1 Indiana residents were affected.